Aptagen, LLC
            
                
                     DNA
            
            Heparanase (HPSE1)
            
            Protein
            
            12 nM nM (reported value)
            
            Salt Solution: 100 mM NaCl, 20 mM KCl, 5 mM MgCl2
            
            RT°C
            
            
                                    NA If the oligo is a known aptamer sequence: For binding studies, perform a refolding protocol to ensure proper function (i.e. binding to antigen or target). Refer to the aptamer reference source for the appropriate refolding parameters and binding conditions. Note: it is unknown whether aptamer functions properly without refolding.             
            
            
            Selected in the presence of 1.5 M NaCl.
                
                            
            
            DNA
            
            Heparanase (HPSE1)
            
            Protein
            
            12 nM nM (reported value)
            
            Salt Solution: 100 mM NaCl, 20 mM KCl, 5 mM MgCl2
            
            RT°C
            
            
                                    NA If the oligo is a known aptamer sequence: For binding studies, perform a refolding protocol to ensure proper function (i.e. binding to antigen or target). Refer to the aptamer reference source for the appropriate refolding parameters and binding conditions. Note: it is unknown whether aptamer functions properly without refolding.             
            
            
            Selected in the presence of 1.5 M NaCl. 
This aptamer showed significant inhibition of heparanase in a Matrigel cell invasion assay, outperforming the polyclonal anti-herparanase antibody used as a positive control.
A 30-nt truncated version of this aptamer including only the stem-loop structure showed similar binding affinity but diminished inhibitory activity.
        
    Heparanase (1.5M NaCl) (ID# 425)
 
                This aptamer showed significant inhibition of heparanase in a Matrigel cell invasion assay, outperforming the polyclonal anti-herparanase antibody used as a positive control.
A 30-nt truncated version of this aptamer including only the stem-loop structure showed similar binding affinity but diminished inhibitory activity.
                
                5'dGpdGpdGpdApdGpdApdCpdApdApdGpdApdApdTpdApdApdApdCpdGpdCpdTpdCpdApdAp  dApdTpdGpdGpdApdCpdTpdTpdTpdTpdGpdApdApdTpdGpdTpdGpdGpdCpdApdApdCpdApdApdAp  dTpdTpdCpdGpdApdCpdApdGpdGpdApdGpdGpdCpdTpdCpdApdCpdApdApdCpdApdGpdGpdCp  3'
                
                
                74
                                    
                    22348.62 g/mole
                
                                    
                    727000 L/(mole·cm)
                
                                    
                    45.83%
                    
                    1.38
                    
                    30.74
                
                
                    
                
                
            
        Note: Information on this aptamer oligo was obtained from the literature and hasn't been validated by Aptagen.
Simmons, SC, et al. Development of novel single-stranded nucleic acid aptamers against the pro-angiogenic and metastatic enzyme heparanase (HPSE1). PLoS One (2012) 7:e37938.
Have your aptamer oligo synthesized ORDER NOW



 
                
We are always looking for ways to improve. Please tell us what you think.